GenSight Biologics (GNST) Withdrawn

Developing gene therapies for rare retinal diseases.

Health Care -

IPO Performance
Latest Trade ()
First Day Return
Return from IPO
 
GenSight Biologics IPO News more
  • .
IPO Data
IPO File Date 07/07/2015
Offer Price
Price Range $13.00 - $15.00
Offer Shares (mm) 4.7
Deal Size ($mm) $65
 
IPO Data
IPO Date
Offer Price
Price Range $13.00 - $15.00
Offer Shares (mm) 4.7
Deal Size ($mm) $$65
 
Underwriters
more
Business Overview
Developing gene therapies for rare retinal diseases.
Developing gene therapies for rare retinal diseases.
more
Company Data
Headquarters Paris, , France
Founded 2012
Employees 23
Website www.gensight-biologics.com
 

Performance vs. IPO Index (IPOUSA)